| Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients G Siravegna, B Mussolin, M Buscarino, G Corti, A Cassingena, ... Nature medicine 21 (7), 795-801, 2015 | 1150 | 2015 |
| Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer A Bardelli, S Corso, A Bertotti, S Hobor, E Valtorta, G Siravegna, ... Cancer discovery 3 (6), 658-673, 2013 | 714 | 2013 |
| Tumor heterogeneity and lesion-specific response to targeted therapy in colorectal cancer M Russo, G Siravegna, LS Blaszkowsky, G Corti, G Crisafulli, ... Cancer discovery 6 (2), 147-153, 2016 | 422 | 2016 |
| The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets E Medico, M Russo, G Picco, C Cancelliere, E Valtorta, G Corti, ... Nature communications 6 (1), 7002, 2015 | 318 | 2015 |
| Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer M Russo, S Misale, G Wei, G Siravegna, G Crisafulli, L Lazzari, G Corti, ... Cancer discovery 6 (1), 36-44, 2016 | 310 | 2016 |
| Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer S Arena, B Bellosillo, G Siravegna, A Martínez, I Canadas, L Lazzari, ... Clinical cancer research 21 (9), 2157-2166, 2015 | 295 | 2015 |
| Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer BO Van Emburgh, S Arena, G Siravegna, L Lazzari, G Crisafulli, G Corti, ... Nature communications 7 (1), 13665, 2016 | 213 | 2016 |
| High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors C Cattoglio, D Pellin, E Rizzi, G Maruggi, G Corti, F Miselli, D Sartori, ... Blood, The Journal of the American Society of Hematology 116 (25), 5507-5517, 2010 | 207 | 2010 |
| Complete mitochondrial genome sequence of the Tyrolean Iceman L Ermini, C Olivieri, E Rizzi, G Corti, R Bonnal, P Soares, S Luciani, ... Current Biology 18 (21), 1687-1693, 2008 | 184 | 2008 |
| Radiologic and genomic evolution of individual metastases during HER2 blockade in colorectal cancer G Siravegna, L Lazzari, G Crisafulli, A Sartore-Bianchi, B Mussolin, ... Cancer Cell 34 (1), 148-162. e7, 2018 | 146 | 2018 |
| Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase K Ruggero, A Guffanti, A Corradin, VK Sharma, G De Bellis, G Corti, ... Journal of virology 88 (7), 3612-3622, 2014 | 142 | 2014 |
| Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer D Oddo, EM Sennott, L Barault, E Valtorta, S Arena, A Cassingena, ... Cancer research 76 (15), 4504-4515, 2016 | 120 | 2016 |
| A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity M Iorio, O Sasso, SI Maffioli, R Bertorelli, P Monciardini, M Sosio, ... ACS chemical biology 9 (2), 398-404, 2014 | 109 | 2014 |
| Specific inactivation of two immunomodulatory SIGLEC genes during human evolution X Wang, N Mitra, I Secundino, K Banda, P Cruz, V Padler-Karavani, ... Proceedings of the National Academy of Sciences 109 (25), 9935-9940, 2012 | 90 | 2012 |
| BCAM and LAMA5 mediate the recognition between tumor cells and the endothelium in the metastatic spreading of KRAS-mutant colorectal cancer A Bartolini, S Cardaci, S Lamba, D Oddo, C Marchiò, P Cassoni, ... Clinical cancer research 22 (19), 4923-4933, 2016 | 87 | 2016 |
| A subset of colorectal cancers with cross-sensitivity to olaparib and oxaliplatin S Arena, G Corti, E Durinikova, M Montone, NM Reilly, M Russo, ... Clinical Cancer Research 26 (6), 1372-1384, 2020 | 85 | 2020 |
| The Complete Mitochondrial Genome of an 11,450-year-old Aurochsen (Bos primigenius) from Central Italy M Lari, E Rizzi, S Mona, G Corti, G Catalano, K Chen, C Vernesi, ... BMC Evolutionary Biology 11, 1-10, 2011 | 76 | 2011 |
| Origins and evolution of the Etruscans’ mtDNA S Ghirotto, F Tassi, E Fumagalli, V Colonna, A Sandionigi, M Lari, S Vai, ... PLoS One 8 (2), e55519, 2013 | 64 | 2013 |
| Patient-derived xenografts and matched cell lines identify pharmacogenomic vulnerabilities in colorectal cancer L Lazzari, G Corti, G Picco, C Isella, M Montone, P Arcella, E Durinikova, ... Clinical Cancer Research 25 (20), 6243-6259, 2019 | 62 | 2019 |
| Evolving neoantigen profiles in colorectal cancers with DNA repair defects G Rospo, A Lorenzato, N Amirouchene-Angelozzi, A Magrì, C Cancelliere, ... Genome medicine 11, 1-22, 2019 | 58 | 2019 |
